What Patients With Breast Cancer Need to Know About ADC-Related Fatigue
Nearly 40% of patients with breast cancer treated with antibody-drug conjugates (ADCs) experienced fatigue, according to recently published study findings. The study’s findings, published in Critical Reviews in Oncology/Hematology, analyzed data from 7 …